Compare Jones Lang LaSalle Inc (JLL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs Health Care Select Sector SPDR Fund — how do they compare? Jones Lang LaSalle Inc trades at $325.29 (market cap $15.12B), while Health Care Select Sector SPDR Fund trades at $160.19. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Jones Lang LaSalle Inc nearer its low. Which is the better fit depends on your goals.
| JLL | XLV | |
|---|---|---|
Market Cap | $15.12B | — |
Sector | Real Estate | — |
52-Week High | $358.66 | $164.48 |
52-Week Low | $253.48 | $129.01 |
Enterprise Value | $18.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JLL trades at $324.44, down 1.88% today, with a bullish technical signal from moving averages and a consensus price target of $405.50 suggesting 25% upside. Recent quarters show consistent earnings beats, with Q1 2026 EPS of $3.43 exceeding the $3.01 estimate. Revenue grew to $26.12B in 2025, and net income margin improved to 3.03%. Positive news highlights AI-driven real estate demand and major financing deals, reinforcing growth prospects.
The outlook for JLL is positive, supported by strong fundamentals, analyst upgrades, and strategic positioning in AI-impacted real estate markets. Key opportunities include continued earnings momentum and valuation upside, while risks involve economic sensitivity and competitive pressures in commercial real estate services.
XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.
XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
